Resources - Oculoplastics

Showing 11 - 20 of 24 resources found in Oculoplastics

Reset

Ophtacath® | Lacrimal duct balloon catheter | DCP

Vignette Ophtacath® | Lacrimal duct balloon catheter | DCP

Ophtacath® is a lacrimal duct balloon catheter kit indicated for the dilation of an obstructed nasolacrimal duct. The balloon catheter works with a disposable inflation system to dilate the obstructed nasolacrimal duct, which is a most efficient solution to treat rapidly and durably the symptoms of epiphora.

Masterka® | Pushed Monocanalicular Nasolacrimal Intubation

Vignette Masterka® | Pushed Monocanalicular Nasolacrimal Intubation

Masterka® is FCI innovative solution for the treatment of congenital nasolacrimal duct obstruction resistant to probing. Unlike the traditional “pulled” technique, Masterka® has no metallic probe or suture attached to it and is therefore not pulled out of the nose.

Ritleng®+ | Autostable Lacrimal Intubation | Procedure

Vignette Ritleng®+ | Autostable Lacrimal Intubation | Procedure

Ritleng®+ is FCI latest autostable bicanalicular nasolacrimal intubation consisting of a silicone tube connected at each extremity to a PEEK thread guide to reduce operating time and trauma for the patients. The intubation is self-retaining thanks to two wider silicone portions on the silicone tube. The surgical procedure is similar to the conventional Ritleng® lacrimal intubation and involves the use of Ritleng® instruments.

StopLoss™ Jones tube Introducer Set

Vignette StopLoss™ Jones tube Introducer Set

The StopLoss™ Jones tube introducer set enables the surgeon to choose the most appropriate diameter and length of the StopLoss™ Jones tube prior to tube insertion.

Preloaded Monoka (LacriJet) and congenital nasolacrimal duct obstruction: Initial results

Vignette Preloaded Monoka (LacriJet) and congenital nasolacrimal duct obstruction: Initial results

Preloaded Monoka (Lacrijet) and congenital nasolacrimal duct obstruction: Initial results

FCI is excited to share the results of a recent study conducted by Bruno Fayet, MD (Paris, France), Jean-Marc Ruban, MD (Lyon, France) and William Katowitz, MD (Philadelphia, USA) on LacriJet®.

This article was published last May, in the ‘French Journal of Ophthalmology’ and highlights the performance of LacriJet® for the management of congenital nasolacrimal duct obstruction (CNLDO).

Questions about our products?

FCI Ophthalmics
[email protected]

Phone : 800-932-4202
Fax : 781-826-9060